Downregulation of filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer

Elizabeth R. Burton, Aneesa Gaffar, Soo Jin Lee, Folashade Adeshuko, Kathleen D. Whitney, Joon Yong Chung, Stephen M. Hewitt, Gloria S. Huang, Gary L. Goldberg, Steven K. Libutti, Mijung Kwon

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Ovarian cancer is the most lethal gynecologic malignancy with a five-year survival rate below 25% for patients with stages III and IV disease. Identifying key mediators of ovarian cancer invasion and metastasis is critical to the development of more effective therapeutic interventions. We previously identified Filamin A interacting protein 1-like (FILIP1L) as an important mediator of cell proliferation and migration. In addition, targeted expression of FILIP1L in tumors inhibited tumor growth in vivo. In our present study, we confirmed that both mRNA and protein expression of FILIP1L were downregulated in ovarian cancer cells compared with normal ovarian epithelial cells. FILIP1L expression was inversely correlated with the invasive potential of ovarian cancer cell lines and clinical ovarian cancer specimens. We also provide evidence that DNA methylation is a mechanism by which FILIP1L is downregulated in ovarian cancer. The CpG island in the FILIP1L promoter was heavily methylated in ovarian cancer cells. Methylation status of the FILIP1L promoter was inversely correlated with FILIP1L expression in ovarian cell lines and clinical ovarian specimens. Reduced methylation in the FILIP1L promoter following treatment with a DNA demethylating agent was associated with restoration of FILIP1L expression in ovarian cancer cells. A transcription activator, cAMP-responsive element binding protein (CREB) was shown to bind to the CREB/ATF site in the CpG island of the FILIP1L promoter. Overall, these findings suggest that downregulation of FILIP1L associated with DNA methylation is related with the invasive phenotype in ovarian cancer and that modulation of FILIP1L expression has the potential to be a target for ovarian cancer therapy.

Original languageEnglish (US)
Pages (from-to)1126-1138
Number of pages13
JournalMolecular Cancer Research
Volume9
Issue number8
DOIs
StatePublished - Aug 2011

Fingerprint

Filamins
Ovarian Neoplasms
Methylation
Down-Regulation
Phenotype
Proteins
CpG Islands
DNA Methylation
Carrier Proteins
Cell Line
Neoplasms

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Oncology

Cite this

Downregulation of filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer. / Burton, Elizabeth R.; Gaffar, Aneesa; Lee, Soo Jin; Adeshuko, Folashade; Whitney, Kathleen D.; Chung, Joon Yong; Hewitt, Stephen M.; Huang, Gloria S.; Goldberg, Gary L.; Libutti, Steven K.; Kwon, Mijung.

In: Molecular Cancer Research, Vol. 9, No. 8, 08.2011, p. 1126-1138.

Research output: Contribution to journalArticle

Burton, ER, Gaffar, A, Lee, SJ, Adeshuko, F, Whitney, KD, Chung, JY, Hewitt, SM, Huang, GS, Goldberg, GL, Libutti, SK & Kwon, M 2011, 'Downregulation of filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer', Molecular Cancer Research, vol. 9, no. 8, pp. 1126-1138. https://doi.org/10.1158/1541-7786.MCR-11-0162
Burton, Elizabeth R. ; Gaffar, Aneesa ; Lee, Soo Jin ; Adeshuko, Folashade ; Whitney, Kathleen D. ; Chung, Joon Yong ; Hewitt, Stephen M. ; Huang, Gloria S. ; Goldberg, Gary L. ; Libutti, Steven K. ; Kwon, Mijung. / Downregulation of filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer. In: Molecular Cancer Research. 2011 ; Vol. 9, No. 8. pp. 1126-1138.
@article{81808c8b11614dde987fcd7ae05aab6b,
title = "Downregulation of filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer",
abstract = "Ovarian cancer is the most lethal gynecologic malignancy with a five-year survival rate below 25{\%} for patients with stages III and IV disease. Identifying key mediators of ovarian cancer invasion and metastasis is critical to the development of more effective therapeutic interventions. We previously identified Filamin A interacting protein 1-like (FILIP1L) as an important mediator of cell proliferation and migration. In addition, targeted expression of FILIP1L in tumors inhibited tumor growth in vivo. In our present study, we confirmed that both mRNA and protein expression of FILIP1L were downregulated in ovarian cancer cells compared with normal ovarian epithelial cells. FILIP1L expression was inversely correlated with the invasive potential of ovarian cancer cell lines and clinical ovarian cancer specimens. We also provide evidence that DNA methylation is a mechanism by which FILIP1L is downregulated in ovarian cancer. The CpG island in the FILIP1L promoter was heavily methylated in ovarian cancer cells. Methylation status of the FILIP1L promoter was inversely correlated with FILIP1L expression in ovarian cell lines and clinical ovarian specimens. Reduced methylation in the FILIP1L promoter following treatment with a DNA demethylating agent was associated with restoration of FILIP1L expression in ovarian cancer cells. A transcription activator, cAMP-responsive element binding protein (CREB) was shown to bind to the CREB/ATF site in the CpG island of the FILIP1L promoter. Overall, these findings suggest that downregulation of FILIP1L associated with DNA methylation is related with the invasive phenotype in ovarian cancer and that modulation of FILIP1L expression has the potential to be a target for ovarian cancer therapy.",
author = "Burton, {Elizabeth R.} and Aneesa Gaffar and Lee, {Soo Jin} and Folashade Adeshuko and Whitney, {Kathleen D.} and Chung, {Joon Yong} and Hewitt, {Stephen M.} and Huang, {Gloria S.} and Goldberg, {Gary L.} and Libutti, {Steven K.} and Mijung Kwon",
year = "2011",
month = "8",
doi = "10.1158/1541-7786.MCR-11-0162",
language = "English (US)",
volume = "9",
pages = "1126--1138",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Downregulation of filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer

AU - Burton, Elizabeth R.

AU - Gaffar, Aneesa

AU - Lee, Soo Jin

AU - Adeshuko, Folashade

AU - Whitney, Kathleen D.

AU - Chung, Joon Yong

AU - Hewitt, Stephen M.

AU - Huang, Gloria S.

AU - Goldberg, Gary L.

AU - Libutti, Steven K.

AU - Kwon, Mijung

PY - 2011/8

Y1 - 2011/8

N2 - Ovarian cancer is the most lethal gynecologic malignancy with a five-year survival rate below 25% for patients with stages III and IV disease. Identifying key mediators of ovarian cancer invasion and metastasis is critical to the development of more effective therapeutic interventions. We previously identified Filamin A interacting protein 1-like (FILIP1L) as an important mediator of cell proliferation and migration. In addition, targeted expression of FILIP1L in tumors inhibited tumor growth in vivo. In our present study, we confirmed that both mRNA and protein expression of FILIP1L were downregulated in ovarian cancer cells compared with normal ovarian epithelial cells. FILIP1L expression was inversely correlated with the invasive potential of ovarian cancer cell lines and clinical ovarian cancer specimens. We also provide evidence that DNA methylation is a mechanism by which FILIP1L is downregulated in ovarian cancer. The CpG island in the FILIP1L promoter was heavily methylated in ovarian cancer cells. Methylation status of the FILIP1L promoter was inversely correlated with FILIP1L expression in ovarian cell lines and clinical ovarian specimens. Reduced methylation in the FILIP1L promoter following treatment with a DNA demethylating agent was associated with restoration of FILIP1L expression in ovarian cancer cells. A transcription activator, cAMP-responsive element binding protein (CREB) was shown to bind to the CREB/ATF site in the CpG island of the FILIP1L promoter. Overall, these findings suggest that downregulation of FILIP1L associated with DNA methylation is related with the invasive phenotype in ovarian cancer and that modulation of FILIP1L expression has the potential to be a target for ovarian cancer therapy.

AB - Ovarian cancer is the most lethal gynecologic malignancy with a five-year survival rate below 25% for patients with stages III and IV disease. Identifying key mediators of ovarian cancer invasion and metastasis is critical to the development of more effective therapeutic interventions. We previously identified Filamin A interacting protein 1-like (FILIP1L) as an important mediator of cell proliferation and migration. In addition, targeted expression of FILIP1L in tumors inhibited tumor growth in vivo. In our present study, we confirmed that both mRNA and protein expression of FILIP1L were downregulated in ovarian cancer cells compared with normal ovarian epithelial cells. FILIP1L expression was inversely correlated with the invasive potential of ovarian cancer cell lines and clinical ovarian cancer specimens. We also provide evidence that DNA methylation is a mechanism by which FILIP1L is downregulated in ovarian cancer. The CpG island in the FILIP1L promoter was heavily methylated in ovarian cancer cells. Methylation status of the FILIP1L promoter was inversely correlated with FILIP1L expression in ovarian cell lines and clinical ovarian specimens. Reduced methylation in the FILIP1L promoter following treatment with a DNA demethylating agent was associated with restoration of FILIP1L expression in ovarian cancer cells. A transcription activator, cAMP-responsive element binding protein (CREB) was shown to bind to the CREB/ATF site in the CpG island of the FILIP1L promoter. Overall, these findings suggest that downregulation of FILIP1L associated with DNA methylation is related with the invasive phenotype in ovarian cancer and that modulation of FILIP1L expression has the potential to be a target for ovarian cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=80051957383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051957383&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-11-0162

DO - 10.1158/1541-7786.MCR-11-0162

M3 - Article

VL - 9

SP - 1126

EP - 1138

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 8

ER -